Kähäri VM - Search Results

1

Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.

Farshchian M, Nissinen L, Siljamäki E, Riihilä P, Piipponen M, Kivisaari A, Kallajoki M, Grénman R, Peltonen J, Peltonen S, Quint KD, Bavinck JNB, Kähäri VM. Farshchian M, et al. Among authors: kahari vm. Oncotarget. 2017 Jul 11;8(28):45825-45836. doi: 10.18632/oncotarget.17573. Oncotarget. 2017. PMID: 28526809 Free PMC article.

2

Integrin alpha 2 beta 1 promotes activation of protein phosphatase 2A and dephosphorylation of Akt and glycogen synthase kinase 3 beta.

Ivaska J, Nissinen L, Immonen N, Eriksson JE, Kähäri VM, Heino J. Ivaska J, et al. Among authors: kahari vm. Mol Cell Biol. 2002 Mar;22(5):1352-9. doi: 10.1128/MCB.22.5.1352-1359.2002. Mol Cell Biol. 2002. PMID: 11839802 Free PMC article.

3

Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells.

Ala-aho R, Grénman R, Seth P, Kähäri VM. Ala-aho R, et al. Among authors: kahari vm. Oncogene. 2002 Feb 14;21(8):1187-95. doi: 10.1038/sj.onc.1205198. Oncogene. 2002. PMID: 11850838

4

Antitumor activity and bystander effect of adenovirally delivered tissue inhibitor of metalloproteinases-3.

Ahonen M, Ala-Aho R, Baker AH, George SJ, Grénman R, Saarialho-Kere U, Kähäri VM. Ahonen M, et al. Among authors: kahari vm. Mol Ther. 2002 Jun;5(6):705-15. doi: 10.1006/mthe.2002.0606. Mol Ther. 2002. PMID: 12027554 Free article.

5

Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation.

Impola U, Toriseva M, Suomela S, Jeskanen L, Hieta N, Jahkola T, Grenman R, Kähäri VM, Saarialho-Kere U. Impola U, et al. Among authors: kahari vm. Int J Cancer. 2003 Mar 1;103(6):709-16. doi: 10.1002/ijc.10902. Int J Cancer. 2003. PMID: 12516088 Free article.

6

Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo.

Ala-aho R, Ahonen M, George SJ, Heikkilä J, Grénman R, Kallajoki M, Kähäri VM. Ala-aho R, et al. Among authors: kahari vm. Oncogene. 2004 Jul 1;23(30):5111-23. doi: 10.1038/sj.onc.1207678. Oncogene. 2004. PMID: 15094779

7

Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer.

Luukkaa M, Vihinen P, Kronqvist P, Vahlberg T, Pyrhönen S, Kähäri VM, Grénman R. Luukkaa M, et al. Among authors: kahari vm. Head Neck. 2006 Mar;28(3):225-34. doi: 10.1002/hed.20322. Head Neck. 2006. PMID: 16302191

8

Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.

Vähä-Koskela MJ, Kallio JP, Jansson LC, Heikkilä JE, Zakhartchenko VA, Kallajoki MA, Kähäri VM, Hinkkanen AE. Vähä-Koskela MJ, et al. Among authors: kahari vm. Cancer Res. 2006 Jul 15;66(14):7185-94. doi: 10.1158/0008-5472.CAN-05-2214. Cancer Res. 2006. PMID: 16849565

9

CIP2A inhibits PP2A in human malignancies.

Junttila MR, Puustinen P, Niemelä M, Ahola R, Arnold H, Böttzauw T, Ala-aho R, Nielsen C, Ivaska J, Taya Y, Lu SL, Lin S, Chan EK, Wang XJ, Grènman R, Kast J, Kallunki T, Sears R, Kähäri VM, Westermarck J. Junttila MR, et al. Among authors: kahari vm. Cell. 2007 Jul 13;130(1):51-62. doi: 10.1016/j.cell.2007.04.044. Cell. 2007. PMID: 17632056 Free article.

10

Matrix metalloproteinase (MMP)-1, -9 and -13 as prognostic factors in salivary gland cancer.

Luukkaa H, Klemi P, Hirsimäki P, Vahlberg T, Kivisaari A, Kähäri VM, Grénman R. Luukkaa H, et al. Among authors: kahari vm. Acta Otolaryngol. 2008 Apr;128(4):482-90. doi: 10.1080/00016480801922895. Acta Otolaryngol. 2008. PMID: 18368586

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page